Our vision
We believe there is a need for simple, sustainable solutions that facilitate improvements in data quality without impacting innovation and freedom of research.
Our aim is to enable a smoother, faster and safer transition from preclinical to clinical testing and drug approval by establishing common guidelines to strengthen the robustness, rigor and validity of research data.